Geir Lund • 1958 • Greåker • 23 roles • 10 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
V VITAMAX AS	Managing Director/CEO	-	2,971,981	50 % indirectly
L LUNDS KLINIKK AS	Managing Director/CEO	1,050,402	115,993	50 % directly
B BIOPHARMA AS	Managing Director/CEO	33,712,688	8,597,842	40.32 % indirectly
P PHARMATECH AS	Managing Director/CEO	505,693,040	51,016,002	40.32 % indirectly
B BIOSAN AS	Managing Director/CEO	9,045,079	10,845,174	40.32 % indirectly
G GME LUND HOLDING AS	Managing Director/CEO	-	29,094,487	40.32 % directly
M MULTILAB ØSTFOLD AS	Managing Director/CEO	5,032,020	2,119,041	40.32 % indirectly
F FARMATEKET AS	Managing Director/CEO	122,516	451,068	40.32 % indirectly
L LUND EIENDOM FREDRIKSTAD AS	Managing Director/CEO	7,636,958	19,805,414	40.32 % indirectly
B BIO-SAN INTERNATIONAL AVD ØSTFOLD G Lund	Managing Director/CEO	-	-	-

Boards

Name	Role	Total operating income	Total equity	Shares
P PHARMAPAC AS	Chairman	-	12,499	50 % directly
V VITAMAX AS	Chairman	-	2,971,981	50 % indirectly
L LUNDS KLINIKK AS	Chairman	1,050,402	115,993	50 % directly
B BIOPHARMA AS	Chairman	33,712,688	8,597,842	40.32 % indirectly
P PHARMATECH AS	Chairman	505,693,040	51,016,002	40.32 % indirectly
B BIOSAN AS	Chairman	9,045,079	10,845,174	40.32 % indirectly
G GME LUND HOLDING AS	Board Member	-	29,094,487	40.32 % directly
M MULTILAB ØSTFOLD AS	Chairman	5,032,020	2,119,041	40.32 % indirectly
F FARMATEKET AS	Chairman	122,516	451,068	40.32 % indirectly
L LUND EIENDOM FREDRIKSTAD AS	Chairman	7,636,958	19,805,414	40.32 % indirectly
B BIO-SAN INTERNATIONAL AVD ØSTFOLD G Lund	Holder	-	-	-
B BIO-SAN ANS	Participant with Joint and Several Liability (Full Responsibility)	-	-	-
L LAVENDULA ANS	Participant with Joint and Several Liability (Full Responsibility)	-	-	-

Last update: Apr 13, 2023

Related industries3

Direct relationships4

MK
Mette Kristin Lund1959
PHARMAPAC AS, BIOPHARMA AS, PHARMATECH AS, BIOSAN AS, GME LUND HOLDING AS, BIO-SAN ANS, VITAMAX AS, MULTILAB ØSTFOLD AS, FARMATEKET AS, LAVENDULA ANS
MW
Markus Wilhelmsen Lund1979
BIOPHARMA AS, GME LUND HOLDING AS
EL
Eline Lund Sælid1981
GME LUND HOLDING AS, LUNDS KLINIKK AS
GA
Geir Andreas Lund1987
GME LUND HOLDING AS

Shares owned by Geir Lund

Name	Share class	Total operating income	Total equity	Share
L LUNDS KLINIKK AS	Ordinære aksjer	1,050,402	115,993	50 % directly
P PHARMAPAC AS	Ordinære aksjer	0	12,499	50 % directly
V VITAMAX AS		0	2,971,981	50 % indirectly
G GME LUND HOLDING AS	Ordinære aksjer	0	29,094,487	40.32 % directly
B BIOPHARMA AS		33,712,688	8,597,842	40.32 % indirectly
P PHARMATECH AS		505,693,040	51,016,002	40.32 % indirectly
B BIOSAN AS		9,045,079	10,845,174	40.32 % indirectly
M MULTILAB ØSTFOLD AS		5,032,020	2,119,041	40.32 % indirectly
F FARMATEKET AS		122,516	451,068	40.32 % indirectly
L LUND EIENDOM FREDRIKSTAD AS		7,636,958	19,805,414	40.32 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025